A recent article released by IBM Watson Health announced a collaboration between IBM Canada and Boehringer Ingelheim Canada Ltd. to test blockchain clinical trials.
Editor's Note: This article originally appeared on IBM's website.
The healthcare industry is undergoing significant changes due to the vast amounts of disparate data being generated. There is a huge need for transformative healthcare solutions where healthcare researchers, providers, and patients have access to a 360-degree view of health data. Blockchain technology provides a highly secure, decentralized framework for data sharing that could accelerate innovation throughout the industry.
Blockchain technology in healthcare has made significant strides in the last few years. IBM entered into research projects with the U.S. Food and Drug Administration and Center for Disease Control, and more recently announced a multi-company health utility network being formed to create an inclusive blockchain network that can benefit multiple members of the healthcare ecosystem in a secure, shared environment. Click here to continue>>
News From Our Partners